Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.41−0.09 (-6.00%)
Close on Nov 12, 2026Market cap $35.81MP/E –Yield –
Serina Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Serina Therapeutics's enterprise value was $13.30M on Nov 10, 2026, against $36.13M a year earlier. Over the last 5 years it ranged from -$6.70M to $71.90M, with a median of $27.02M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $13.30M | +16.8% |
| 2025 | Dec 31, 2025 | $11.38M | -72.4% |
| 2024 | Dec 31, 2024 | $41.31M | +192.9% |
| 2023 | Dec 29, 2023 | $14.11M | -31.0% |
| 2022 | Dec 30, 2022 | $20.44M | -49.6% |
| 2021 | Dec 31, 2021 | $40.58M | -27.6% |
| 2020 | Dec 31, 2020 | $56.09M | -14.2% |
| 2019 | Dec 31, 2019 | $65.36M | -30.9% |
| 2018 | Dec 31, 2018 | $94.58M | – |
See a number that looks wrong?